Plasma Vitamin C and Risk of Late Graft Failure in Kidney Transplant Recipients: Results of the TransplantLines Biobank and Cohort Study

Autor: Robin P. F. Dullaart, Stephan J. L. Bakker, Stefan P Berger, Nicolas I. Bustos, Camilo G. Sotomayor, Gerjan Navis, Manuela Yepes-Calderón, Ramón Rodrigo, Diego Arauna, Martin H. de Borst
Přispěvatelé: Groningen Institute for Organ Transplantation (GIOT), Groningen Kidney Center (GKC), Value, Affordability and Sustainability (VALUE)
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Vitamin
medicine.medical_specialty
HEMODIALYSIS
BLOOD
Physiology
CYCLOSPORINE-A
medicine.medical_treatment
graft failure
Clinical Biochemistry
030232 urology & nephrology
Renal function
kidney transplantation
vitamin C
RM1-950
030204 cardiovascular system & hematology
high-density lipoprotein
Biochemistry
Gastroenterology
Article
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
INFLAMMATION
QUALITY-OF-LIFE
Internal medicine
medicine
oxidative stress
Renal replacement therapy
Molecular Biology
ATTENUATES OXIDATIVE STRESS
triglycerides
Dialysis
Kidney transplantation
ALL-CAUSE MORTALITY
NITRIC-OXIDE
Vitamin C
Proportional hazards model
business.industry
RENAL REPLACEMENT THERAPY
Cell Biology
medicine.disease
surgical procedures
operative

chemistry
CARDIOVASCULAR-DISEASE
Hemodialysis
Therapeutics. Pharmacology
business
Zdroj: Antioxidants
Antioxidants (Basel, Switzerland), 10(5):631. MDPI AG
Antioxidants, Vol 10, Iss 631, p 631 (2021)
Volume 10
Issue 5
ISSN: 2076-3921
Popis: Recent studies have shown that depletion of vitamin C is frequent in outpatient kidney transplant recipients (KTR) and that vitamin C is inversely associated with risk of death. Whether plasma vitamin C is associated with death-censored kidney graft failure remains unknown. We investigated KTR who participated in the TransplantLines Insulin Resistance and Inflammation Biobank and Cohort Study. The primary outcome was graft failure (restart of dialysis or re-transplantation). Overall and stratified (pinteraction <
0.1) multivariable-adjusted Cox regression analyses are presented here. Among 598 KTR (age 51 ± 12 years-old
55% males), baseline median (IQR) plasma vitamin C was 44.0 (31.0–55.3) µmol/L. Through a median follow-up of 9.5 (IQR, 6.3‒10.2) years, 75 KTR developed graft failure (34, 26, and 15 events over increasing tertiles of vitamin C, log-rank p <
0.001). Plasma vitamin C was inversely associated with risk of graft failure (HR per 1–SD increment, 0.69
95% CI 0.54–0.89
p = 0.004), particularly among KTR with triglycerides ≥1.9 mmol/L (HR 0.46
95% CI 0.30–0.70
p <
0.001
pinteraction = 0.01) and among KTR with HDL cholesterol ≥0.91 mmol/L (HR 0.56
95% CI 0.38–0.84
p = 0.01
pinteraction = 0.04). These findings remained materially unchanged in multivariable-adjusted analyses (donor, recipient, and transplant characteristics, including estimated glomerular filtration rate and proteinuria), were consistent in categorical analyses according to tertiles of plasma vitamin C, and robust after exclusion of outliers. Plasma vitamin C in outpatient KTR is inversely associated with risk of late graft failure. Whether plasma vitamin C‒targeted therapeutic strategies represent novel opportunities to ease important burden of graft failure necessitates further studies.
Databáze: OpenAIRE